A cohort study of azithromycin treatment failure in women with Chlamydia infections.
Women attending sexual health centres in Australia were recruited and followed for 56 days post-treatment with 1g azithromycin. Sexual behaviour information, detection of Y chromosome DNA, and chlamydia genotyping was used to differentiate between treatment failure and reinfection.